Adverse Events.

Abbreviations: AZA, azathioprine; IFN, interferon; PY, person-years.1P-values for AZA vs. IFN comparison were obtained through χ2 test with one degree of freedom for rate comparison, discontinued interventions due to adverse events, seriousness of adverse event, and correlation of event with treatment.2All 95% CI were estimated using the exact method.3Liver enzymes, thyroid function and bilirubin level.4The sum does not add up to the total because of some missing values.5Seriousness judged by the treating neurologist. SAEs classified according to the National Cancer Institute Common Terminology Criteria for AE [21] are reported in Table S1 in File S1.Adverse Events.

Tags
Data and Resources
To access the resources you must log in

This item has no data

Identity

Description: The Identity category includes attributes that support the identification of the resource.

Field Value
PID https://www.doi.org/10.1371/journal.pone.0121686.t004
PID https://www.doi.org/10.1371/journal.pone.0227424.t004
PID https://www.doi.org/10.1371/journal.pone.0172610.t004
PID https://www.doi.org/10.1371/journal.pone.0119479.t002
PID https://www.doi.org/10.1371/journal.pone.0036077.t004
PID https://www.doi.org/10.1371/journal.pone.0190849.t002
PID https://www.doi.org/10.1371/journal.pone.0195574.t003
PID https://www.doi.org/10.1371/journal.pone.0179254.t002
PID https://www.doi.org/10.1371/journal.pmed.1001783.t005
PID https://www.doi.org/10.1371/journal.pone.0175922.t004
PID https://www.doi.org/10.1371/journal.pone.0088403.t007
PID https://www.doi.org/10.1371/journal.pmed.1002210.t004
PID https://www.doi.org/10.1371/journal.pone.0036979.t002
PID https://www.doi.org/10.1371/journal.pone.0128754.t005
PID https://www.doi.org/10.1371/journal.pone.0113371.t004
PID https://www.doi.org/10.1371/journal.pone.0157065.t004
PID https://www.doi.org/10.1371/journal.pone.0035708.t004
PID https://www.doi.org/10.1371/journal.pone.0012367.t003
PID https://www.doi.org/10.1371/journal.pone.0037885.t002
PID https://www.doi.org/10.1371/journal.pone.0091838.t004
URL https://figshare.com/articles/Adverse_events_/11571441
URL http://dx.doi.org/10.1371/journal.pone.0172610.t004
URL https://figshare.com/articles/_Adverse_events_/976894
URL http://dx.doi.org/10.1371/journal.pone.0037885.t002
URL https://figshare.com/articles/_Adverse_Events_/315153
URL http://dx.doi.org/10.1371/journal.pone.0190849.t002
URL http://dx.doi.org/10.1371/journal.pone.0119479.t002
URL http://dx.doi.org/10.1371/journal.pone.0179254.t002
URL https://figshare.com/articles/_Adverse_Events_/288667
URL http://dx.doi.org/10.1371/journal.pone.0113371.t004
URL https://figshare.com/articles/Adverse_events_/4971458
URL http://dx.doi.org/10.1371/journal.pone.0121686.t004
URL http://dx.doi.org/10.1371/journal.pone.0088403.t007
URL https://figshare.com/articles/_Adverse_Events_/1244221
URL http://dx.doi.org/10.1371/journal.pone.0035708.t004
URL http://dx.doi.org/10.1371/journal.pmed.1001783.t005
URL https://figshare.com/articles/_Adverse_events_/296528
URL http://dx.doi.org/10.1371/journal.pone.0036077.t004
URL http://dx.doi.org/10.1371/journal.pone.0128754.t005
URL https://figshare.com/articles/Adverse_Events_/4687978
URL https://figshare.com/articles/Adverse_events_/4509935
URL https://figshare.com/articles/Adverse_events_/5130460
URL http://dx.doi.org/10.1371/journal.pone.0175922.t004
URL https://figshare.com/articles/_Adverse_events_/929795
URL https://figshare.com/articles/_Adverse_Events_/1328948
URL http://dx.doi.org/10.1371/journal.pone.0227424.t004
URL https://figshare.com/articles/Adverse_events_/6195806
URL https://figshare.com/articles/_Adverse_events_/503457
URL http://dx.doi.org/10.1371/journal.pone.0012367.t003
URL https://figshare.com/articles/Adverse_events_/5776224
URL https://figshare.com/articles/_Adverse_events_/315302
URL http://dx.doi.org/10.1371/journal.pone.0091838.t004
URL http://dx.doi.org/10.1371/journal.pmed.1002210.t004
URL http://dx.doi.org/10.1371/journal.pone.0157065.t004
URL https://figshare.com/articles/dataset/_Adverse_events_/503457
URL http://dx.doi.org/10.1371/journal.pone.0195574.t003
URL http://dx.doi.org/10.1371/journal.pone.0036979.t002
URL https://figshare.com/articles/_Adverse_events_/1311141
URL https://figshare.com/articles/_Adverse_Events_/1361124
URL https://figshare.com/articles/_Adverse_Events_/1450032
URL https://figshare.com/articles/Adverse_events_/3441488
Access Modality

Description: The Access Modality category includes attributes that report the modality of exploitation of the resource.

Field Value
Access Right Open Access
Attribution

Description: Authorships and contributors

Field Value
Author Dupuis, Luc
Author Dengler, Reinhard
Author T. Heneka, Michael
Author Meyer, Thomas
Author Zierz, Stephan
Author Kassubek, Jan
Author Fischer, Wilhelm
Author Steiner, Franziska
Author Lindauer, Eva
Author Otto, Markus
Author Dreyhaupt, Jens
Author Grehl, Torsten
Author Hermann, Andreas
Author S. Winkler, Andrea
Author Bogdahn, Ulrich
Author Benecke, Reiner
Author Schrank, Bertold
Author Wessig, Carsten
Author Grosskreutz, Julian
Author C. Ludolph, Albert
Publishing

Description: Attributes about the publishing venue (e.g. journal) and deposit location (e.g. repository)

Field Value
Collected From figshare
Hosted By figshare
Publication Date 2015-01-01
Publisher Figshare
Additional Info
Field Value
Language UNKNOWN
Resource Type Dataset
keyword Ant ônio Pedro University Hospital
keyword β interferons
keyword 65 β interferons
keyword 73 β interferons
system:type dataset
Management Info
Field Value
Source https://science-innovation-policy.openaire.eu/search/dataset?datasetId=dedup_wf_001::da96ee248b58271035d56962c4ec7ab3
Author jsonws_user
Last Updated 1 January 2021, 16:47 (CET)
Created 1 January 2021, 16:47 (CET)